119 related articles for article (PubMed ID: 21744351)
61. Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.
Sudhadevi T; Ha AW; Ebenezer DL; Fu P; Putherickal V; Natarajan V; Harijith A
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158685. PubMed ID: 32169655
[TBL] [Abstract][Full Text] [Related]
62. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
[TBL] [Abstract][Full Text] [Related]
63. Mechanisms of lysolipid phosphate effects on cellular survival and proliferation.
Goetzl EJ; Lee H; Dolezalova H; Kalli KR; Conover CA; Hu YL; Azuma T; Stossel TP; Karliner JS; Jaffe RB
Ann N Y Acad Sci; 2000 Apr; 905():177-87. PubMed ID: 10818453
[TBL] [Abstract][Full Text] [Related]
64. Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.
Si J; Su Y; Wang Y; Yan YL; Tang YL
Int J Clin Exp Med; 2015; 8(10):17880-90. PubMed ID: 26770382
[TBL] [Abstract][Full Text] [Related]
65. Aiming drug discovery at lysophosphatidic acid targets.
Tigyi G
Br J Pharmacol; 2010 Sep; 161(2):241-70. PubMed ID: 20735414
[TBL] [Abstract][Full Text] [Related]
66. Roles of lysophosphatidic acid (LPA) receptor-2 (LPA
Okuda A; Takai M; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Int J Radiat Biol; 2023; 99(12):1925-1933. PubMed ID: 37523658
[TBL] [Abstract][Full Text] [Related]
67. Lysophosphatidic acid in atherosclerotic diseases.
Schober A; Siess W
Br J Pharmacol; 2012 Oct; 167(3):465-82. PubMed ID: 22568609
[TBL] [Abstract][Full Text] [Related]
68. The Emerging Role of LPA as an Oncometabolite.
Karalis T; Poulogiannis G
Cells; 2024 Apr; 13(7):. PubMed ID: 38607068
[TBL] [Abstract][Full Text] [Related]
69. New metabolically stabilized analogues of lysophosphatidic acid: agonists, antagonists and enzyme inhibitors.
Prestwich GD; Xu Y; Qian L; Gajewiak J; Jiang G
Biochem Soc Trans; 2005 Dec; 33(Pt 6):1357-61. PubMed ID: 16246118
[TBL] [Abstract][Full Text] [Related]
70. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders.
Flores-López M; García-Marchena N; Pavón-Morón FJ; Requena-Ocaña N; Sánchez-Marín L; Martín-Chaves L; García-Medina M; Pedraza C; Castilla-Ortega E; Ruiz JJ; Rodríguez de Fonseca F; Araos P; Serrano A
Transl Psychiatry; 2023 Jun; 13(1):215. PubMed ID: 37344453
[TBL] [Abstract][Full Text] [Related]
71. Lysophosphatidic acid in carcinogenesis and tumor development.
Albrecht W
EXCLI J; 2018; 17():980-982. PubMed ID: 30564077
[No Abstract] [Full Text] [Related]
72. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
73. Alteration of chromosome structure impacts gene expressions implicated in pancreatic ductal adenocarcinoma cells.
Han W; Shi D; Yang Q; Li X; Zhang J; Peng C; Yan F
BMC Genomics; 2024 Feb; 25(1):206. PubMed ID: 38395755
[TBL] [Abstract][Full Text] [Related]
74. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
Balijepalli P; Sitton CC; Meier KE
Cells; 2021 Aug; 10(8):. PubMed ID: 34440828
[TBL] [Abstract][Full Text] [Related]
75. The FOXM1/ATX signaling contributes to pancreatic cancer development.
Xie D; Yu S; Li L; Quan M; Gao Y
Am J Transl Res; 2020; 12(8):4478-4487. PubMed ID: 32913521
[TBL] [Abstract][Full Text] [Related]
76. Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ.
He Y; Han SB; Geng YN; Yang SL; Wu YM
J Gynecol Oncol; 2020 May; 31(3):e28. PubMed ID: 31912682
[TBL] [Abstract][Full Text] [Related]
77. Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study.
Younis S; Rashid S
PLoS One; 2017; 12(12):e0189154. PubMed ID: 29211777
[TBL] [Abstract][Full Text] [Related]
78. Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.
Zuckerman V; Sokolov E; Swet JH; Ahrens WA; Showlater V; Iannitti DA; Mckillop IH
Oncotarget; 2016 Jan; 7(3):2951-67. PubMed ID: 26701886
[TBL] [Abstract][Full Text] [Related]
79. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
[TBL] [Abstract][Full Text] [Related]
80. Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.
Lv GM; Li P; Wang WD; Wang ShK; Chen JF; Gong YL
J Surg Oncol; 2011 Nov; 104(6):685-91. PubMed ID: 21744351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
